Method of use of enantiomers of trans-indeno[1,2-b]-1,4-oxazines
申请人:Merck & Co., Inc.
公开号:US04431647A1
公开(公告)日:1984-02-14
The (R,R)-enantiomers of trans-indeno[1,2-b]-1,4-oxazines demonstrate dopaminergic activity, whereas the (S,S)-enantiomers demonstrate .alpha.-adrenergic antagonist activity. They are prepared by cyclization of the appropriate chiral 2-amino-1-hydroxyindane.